| Issue Date | Title | Author(s) |
| 2017-12-11 | Dosimetrically administered nebulized morphine for breathlessness in very severe chronic obstructive pulmonary disease: A randomized, controlled trial | Janowiak, P; Krajnik, M; Podolec, Z; Bandurski, T; Damps-Konstańska, I; Sobański, P; Currow, DC; Jassem, E |
| 2016-02-01 | Blinded Patient Preference for Morphine Compared to Placebo in the Setting of Chronic Refractory Breathlessness - An Exploratory Study | Ferreira, DH; Silva, JP; Quinn, S; Abernethy, AP; Johnson, MJ; Oxberry, SG; Currow, DC |
| 2009-03-01 | A randomized placebo-controlled trial on the effectiveness of an herbal formula to alleviate menopausal vasomotor symptoms | Van Der Sluijs, CP; Bensoussan, A; Chang, S; Baber, R |
| 2015-09-01 | The effect of methylphenidate on fatigue in advanced cancer: An aggregated N-of-1 trial | Mitchell, GK; Hardy, JR; Nikles, CJ; Carmont, SAS; Senior, HE; Schluter, PJ; Good, P; Currow, DC |
| 2012-05-01 | The Acute Haemodynamic Effect of Nebulised Frusemide in Stable, Advanced Heart Failure | Newton, PJ; Davidson, PM; Krum, H; Ollerton, R; Macdonald, P |
| 2011-05-01 | Aggregating single patient (n-of-1) trials in populations where recruitment and retention was difficult: The case of palliative care | Nikles, J; Mitchell, GK; Schluter, P; Good, P; Hardy, J; Rowett, D; Shelby-James, T; Vohra, S; Currow, D |
| 2017-07-01 | A pragmatic, phase III, multisite, double-blind, placebo-controlled, parallel-Arm, dose increment randomised trial of regular, low-dose extended-release morphine for chronic breathlessness: Breathlessness, Exertion and Morphine Sulfate (BEAMS) study protocol | Currow, D; Watts, GJ; Johnson, M; McDonald, CF; Miners, JO; Somogyi, AA; Denehy, L; McCaffrey, N; Eckert, DJ; McCloud, P; Louw, S; Lam, L; Greene, A; Fazekas, B; Clark, KC; Fong, K; Agar, MR; Joshi, R; Kilbreath, S; Ferreira, D; Ekström, M |
| 2016-02-01 | Effects of low-dose morphine on perceived sleep quality in patients with refractory breathlessness: A hypothesis generating study | Martins, RT; Currow, DC; Abernethy, AP; Johnson, MJ; Toson, B; Eckert, DJ |
| 2020 | Predictors of duloxetine response in patients with neuropathic cancer pain: a secondary analysis of a randomized controlled trial—JORTC-PAL08 (DIRECT) study | Matsuoka, H; Iwase, S; Miyaji, T; Kawaguchi, T; Ariyoshi, K; Oyamada, S; Satomi, E; Ishiki, H; Hasuo, H; Sakuma, H; Tokoro, A; Matsuda, Y; Tahara, K; Otani, H; Ohtake, Y; Tsukuura, H; Matsumoto, Y; Hasegawa, Y; Kataoka, Y; Otsuka, M; Sakai, K; Nakura, M; Morita, T; Yamaguchi, T; Koyama, A |
| 2016-09 | Can atorvastatin with metformin change the natural history of prostate cancer as characterized by molecular, metabolomic, imaging and pathological variables? A randomized controlled trial protocol. | Roberts, MJ; Yaxley, JW; Coughlin, GD; Gianduzzo, TRJ; Esler, RC; Dunglison, NT; Chambers, SK; Medcraft, RJ; Chow, CWK; Schirra, HJ; Richards, RS; Kienzle, N; Lu, M; Brereton, I; Samaratunga, H; Perry-Keene, J; Payton, D; Oyama, C; Doi, SA; Lavin, MF; Gardiner, RA |
